JPS60197611A - External agent for skin - Google Patents
External agent for skinInfo
- Publication number
- JPS60197611A JPS60197611A JP59052496A JP5249684A JPS60197611A JP S60197611 A JPS60197611 A JP S60197611A JP 59052496 A JP59052496 A JP 59052496A JP 5249684 A JP5249684 A JP 5249684A JP S60197611 A JPS60197611 A JP S60197611A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- group
- alkyl
- carbon atoms
- branched alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Abstract
Description
【発明の詳細な説明】
この発明は、安全性が高く、界面活性機能もすぐれ、し
かも皮膚に対する作用も温和なニコチン酸誘導体を界面
活性剤もしくは静菌剤またはこれら固剤として利用する
ことを目的とする皮膚外用剤に関するものである。[Detailed Description of the Invention] The purpose of the present invention is to utilize nicotinic acid derivatives, which are highly safe, have excellent surfactant functions, and have mild effects on the skin, as surfactants, bacteriostatic agents, or solid agents thereof. The present invention relates to a skin preparation for external use.
ニコチン酸はナイアシンとも呼ばれるビタミンB、で生
体内において°生命現象を維持する上で重要な酸化還元
酵素の補酵素ニコチンアミドアデニンジヌクレオチド(
N A p士)とそのリン酸エステル(N A D p
士)を構成する。また、ペラグラ治療、慢性アルコール
中毒、しもやけ、舌炎の治療などに有効であることもよ
く知られている。Nicotinic acid is a vitamin B, also called niacin, and is a coenzyme of nicotinamide adenine dinucleotide (oxidoreductase), which is important in maintaining life phenomena in living organisms.
N A D p
constitutes a It is also well known to be effective in treating pellagra, chronic alcoholism, chilblains, glossitis, etc.
一方、アルキルピリヅニウム塩、アルキルトリメチルア
ンモニウム塩、アルキルヅメチルベンジルアンモニウム
塩などはリンス剤、殺菌剤、柔軟剤、帯電防止1剤など
の広い分野で汎用されている陽イオン界面活性剤である
が、これらを皮膚ニ塗布したままのときには、界面活性
剤特有の副作用である強い刺激性があり、主としてヘア
コンデイショナー、トリートメントなどの化粧料以外に
使用するのは好ましくない。On the other hand, alkylpyridunium salts, alkyltrimethylammonium salts, alkyldumethylbenzylammonium salts, etc. are cationic surfactants that are widely used in a wide range of fields such as rinse agents, disinfectants, softeners, and antistatic agents. However, when these are applied to the skin, they cause strong irritation, which is a side effect peculiar to surfactants, and it is not preferable to use them for purposes other than cosmetics, such as hair conditioners and treatments.
この発明はこのような現状に着目してなされたものであ
り、下記一般式CAIまたは〔B〕で表わされるニコチ
ン酸誘導体を含有することを特徴とする皮膚外用剤−を
提供するものである。The present invention has been made in view of the current situation, and provides an external skin preparation characterized by containing a nicotinic acid derivative represented by the following general formula CAI or [B].
記
[A] [B’:]
(式中、klは炭素数8〜30の直鎖もしくは分枝アル
キル基、R2は炭素数1〜30の直鎖もしくは分枝アル
キル基およびフェニル基、Xはハロゲン基を表わす。)
以下、この発明の詳細を述べる。[A] [B':] (wherein kl is a straight chain or branched alkyl group having 8 to 30 carbon atoms, R2 is a straight chain or branched alkyl group having 1 to 30 carbon atoms and a phenyl group, and X is (Represents a halogen group.) The details of this invention will be described below.
まず、この発明に適用される一般式〔A〕で示される1
−アルキル−3−カルバミドピリヅニウム塩および一般
式〔B〕で示される1−アルキル−3−アルキルカルバ
ミドピリジニウム塩は、この発明者うがニコチン酸アミ
ドの生理的効果効能に注目して検討した結果見出したも
ので、補酵素NAD+モデル化合物であり、明らかに天
然系界面活性剤に分類されるものである。そして、この
ような化合物が界面領域に存在するときには、油性成分
をきわめて容易に乳化することができるが、これはおそ
らくピリジニウム骨格と他の配合成分との間に広義の電
荷移動錯体が形成されるものと考えられるが、形成され
たミセルやエマルジョンはきわめて安定性がよく、界面
活性機能および静菌機能を有し、従来の陽イオン界面活
性剤では得られない低刺激性の化粧水、乳液、クリーム
、ヘアコンディショナー等の皮膚外用剤に適用できるの
である。First, 1 represented by the general formula [A] applied to this invention
-Alkyl-3-carbamide pyridinium salts and 1-alkyl-3-alkylcarbamide pyridinium salts represented by general formula [B] were investigated by the present inventor, focusing on the physiological effects of garnicotinamide. As a result, it is a coenzyme NAD+ model compound and is clearly classified as a natural surfactant. And when such compounds are present in the interfacial region, oily ingredients can be emulsified very easily, probably due to the formation of broad charge transfer complexes between the pyridinium skeleton and other formulation ingredients. However, the micelles and emulsions formed are extremely stable and have surfactant and bacteriostatic functions, making them useful for hypoallergenic lotions, emulsions, and emulsions that cannot be obtained with conventional cationic surfactants. It can be applied to external skin preparations such as creams and hair conditioners.
このようなニコチン酸誘導体を合成する方法は数多くあ
るが、たとえばCADIに対してはニコチン酸アミドに
エタノール、ジメチルホルムアミド等の溶媒上所望のア
ルキルハライドを反応させる方法が有利であり、また、
〔B〕に対してはニコチン酸に過剰の塩1化チオニルな
どの塩素化剤を作用させニコチン酸クロライドとし、こ
れにベンゼン等ノ溶媒下、トリエチルアミン等の塩基存
在下、アルキルアミンを作用させて3−アルキルカルツ
クミドピリジンを生成せしめ、さらに、これにエタノー
ル等の溶媒下、所望のアルキレノ1ライドを反応させる
という方法が有利である。これら方法の具体例はつぎの
とおりである。There are many methods for synthesizing such nicotinic acid derivatives, but for CADI, for example, a method in which nicotinic acid amide is reacted with a desired alkyl halide in a solvent such as ethanol or dimethylformamide is advantageous;
For [B], nicotinic acid is reacted with an excess chlorinating agent such as thionyl monochloride to form nicotinic acid chloride, and this is reacted with an alkylamine in a solvent such as benzene and in the presence of a base such as triethylamine. An advantageous method is to produce a 3-alkylcalcumidopyridine and then react it with a desired alkylenolide in a solvent such as ethanol. Specific examples of these methods are as follows.
[Alの合成例:
ニコチン酸アミド1.22g(0,01mol )をヅ
メチルホルムアミド15 ml に溶解し、ステアリル
クロフィト2.89gC0,01mol)を加え、還流
下2時間反応させ、ついで室温まで放冷した。[Synthesis example of Al: Dissolve 1.22 g (0.01 mol) of nicotinic acid amide in 15 ml of dimethylformamide, add 2.89 g (0.01 mol) of stearyl crophyte, react under reflux for 2 hours, and then leave to room temperature. It got cold.
生成した白色結晶を吸引濾過し、エーテルで洗浄し、2
.5gの1−ステアリル−3−カルバミドピリヅニウム
クロライドを得た。一方濾液のジメチルホルムアミド溶
液を数ml になるまで濃縮し、一度加熱した後、水冷
下にて一昼夜放置して、同一物1.2gを得た。この合
成例における全収率は90%であった。The white crystals formed were suction filtered, washed with ether, and
.. 5 g of 1-stearyl-3-carbamidopyridunium chloride was obtained. On the other hand, the dimethylformamide solution of the filtrate was concentrated to several ml, heated once, and left overnight under water cooling to obtain 1.2 g of the same product. The overall yield in this synthesis example was 90%.
〔B〕の合成例:
ニコチン酸1.85 g (0,015mol ) +
c塩化チオニルlQml を加え、70〜80℃にて1
時間撹拌した。反応後場化チオニルを蒸留によって除き
、ニコチン酸クロライドの結晶を密封して保存した。−
万、ステアリルアミン2.70g(0,01mol )
をベンゼン100m1 に溶解し、さらにトリエチルア
ミン10m1を加えた混合液に前記ノニコチン酸クロラ
イドを室温下で加え、後55〜60℃にて2時間撹拌し
た。反応後40m1 の水を加え、氷冷上静置し、生成
した結晶−を濾別し、これをn−ヘキサン−ベンゼンに
で再結晶し、3−ステアリルカルバミドピリジン3.2
0gを得た。Synthesis example of [B]: Nicotinic acid 1.85 g (0,015 mol) +
c Add lQml of thionyl chloride and incubate at 70-80°C.
Stir for hours. After the reaction, the converted thionyl was removed by distillation, and the nicotinic acid chloride crystals were sealed and stored. −
1,000, stearylamine 2.70g (0.01mol)
was dissolved in 100 ml of benzene, and 10 ml of triethylamine was added thereto, and the nonicotinic acid chloride was added at room temperature, followed by stirring at 55 to 60°C for 2 hours. After the reaction, 40 ml of water was added, the mixture was allowed to stand on ice, and the formed crystals were filtered and recrystallized from n-hexane-benzene to give 3.2 ml of 3-stearylcarbamide pyridine.
Obtained 0g.
得られた結晶、1. B B g (5mmol)に2
0m1 のエタノールを加え、ついでベンノルクロライ
ド2.52g (20mmol )をこれに加え、還流
下5時間反応させた。反応後エタノールを蒸留によって
除き、生成した結晶を石油エーテル−ベンゼンを用いて
再結晶し、2.34gの1−ベンノル−3−ステアリル
カルバミドピリノニウムクロライドが得られた。Obtained crystals: 1. 2 in B B g (5 mmol)
0 ml of ethanol was added, and then 2.52 g (20 mmol) of benol chloride was added thereto, and the mixture was reacted under reflux for 5 hours. After the reaction, ethanol was removed by distillation, and the resulting crystals were recrystallized using petroleum ether-benzene to obtain 2.34 g of 1-bennol-3-stearylcarbamide pyrinonium chloride.
以上述べたこの発明の皮膚外用剤を通常の化粧料に利用
しようとするときには公知の配合成分を随時加えればよ
く、また、必要に応じて、保湿剤、増粘安定剤、防腐剤
、着色剤、着香料等を添加してもよい。このようにして
作られた化粧料は長期間保存しても広い温度領域で安定
性を保ち、皮膚に対する安全性はきわめて高くしかも優
れた作用効果を示して良好な使用感触を与えるものであ
るから、その商品価値は非常に高いものであると言うこ
とができる。When the skin external preparation of the present invention described above is to be used in ordinary cosmetics, known ingredients may be added as needed, and if necessary, moisturizers, thickening stabilizers, preservatives, and colorants may be added. , flavoring agents, etc. may be added. Cosmetics made in this way remain stable over a wide temperature range even when stored for long periods of time, are extremely safe for the skin, and exhibit excellent effects and feel when used. It can be said that its commercial value is extremely high.
以下この発明の実施例を示す。なお、配合割合(%)は
すべて重量%である。Examples of this invention will be shown below. In addition, all compounding ratios (%) are weight %.
〔実施例1〕 つぎに示す組成のクリームリンスを調製した。[Example 1] A cream rinse having the following composition was prepared.
第1群:
1−ステアリル−3−カルバミドピリヅニウムクロライ
ド 0.4%セトステアリルアノにコール 2.5
パラフインワツクス 1.0
パルミチン酸イソプロピル 0.5
オリーブ油 0.5
香料 0.3
防腐剤 。、2
第2群:
色素 適量
精製水 残り全部
すなわち、まず第1群の混合物を80℃に加熱溶解し、
これに、第2群の80℃溶液を加え、ホモミキサーで均
質化処理をした後冷却した。得られたクリームリンスは
45℃のオーブンテストの結果において3力月以上も安
定であり、刺激性はな? 循用感1も非常に優れていた
。なお、1−ステアリル−3−カルバミドピリヅニウム
クロライドの代わりに、塩素以外の臭素、フッ素、ヨウ
素からなるハライドを用いて全く同様の処理を行ないク
リームリンスを調製したが、いずれも同様の性状を示し
た。Group 1: 1-stearyl-3-carbamidopyridunium chloride 0.4% cetostearyl anocoal 2.5 paraffin wax 1.0 isopropyl palmitate 0.5 olive oil 0.5 fragrance 0.3 preservative. , 2 2nd group: Pigment Appropriate amount of purified water The rest, that is, first, dissolve the mixture of the 1st group by heating to 80 ° C.
The 80° C. solution of the second group was added to this, homogenized using a homomixer, and then cooled. The obtained cream rinse was stable for more than 3 months in an oven test at 45°C, and was not irritating. The circulation feeling 1 was also very good. A cream rinse was prepared using a halide other than chlorine consisting of bromine, fluorine, and iodine in place of 1-stearyl-3-carbamidopyridunium chloride, but the cream rinse had the same properties. Indicated.
〔実施例2〕 つぎに示す組成のクレンジングローンヨンを調製した。[Example 2] A cleansing lawn with the following composition was prepared.
調製手順は実施例1と全(同じである。The preparation procedure is the same as in Example 1.
第1群:
1−セチル−3−カルバミドピリヅニウムクロライド
0.8%セトステアリルアルコール 1.2
ワセリン 5.0
流動パラフイン 11.0
パルミチン酸イソプロピル 2.0
香料 0.1
防腐剤 0.2
第2群:
1.3−ブチレングリコール 5.0
精製水 74.7
得られたクレンヅングローションは45℃のオーブンテ
ストにおいても3力月以上安定であり、刺激性はな(、
使用感は非常に良好であった。Group 1: 1-cetyl-3-carbamidopyridunium chloride
0.8% cetostearyl alcohol 1.2 Vaseline 5.0 Liquid paraffin 11.0 Isopropyl palmitate 2.0 Fragrance 0.1 Preservative 0.2 Group 2: 1.3-Butylene glycol 5.0 Purified water 74 .7 The resulting cleansing lotion was stable for more than 3 months in an oven test at 45°C, and was non-irritating.
The usability was very good.
〔実施例3〕 つぎに示す組成のスキンクリームを調製した。[Example 3] A skin cream having the composition shown below was prepared.
第1群:
1−ステアリル−3−カルバミドピリノニウムクロライ
ド 1,0%セトステアリルアルコール 5.0
スクワラン 10.0
ステアリン酸 8.0
ミツロウ 2.0
オリーブ油 3.0
香料 0.1
防腐剤 0.2
第2群:
1.3−ブチレングリコール 8.0
グリセリン 4.0
精製水 58.7
調製手順は実施例1と全く同じであり、得られたスキン
クリームは45℃のオーブンテストにおいても3力月以
上も安定であり、刺激性がなく使用感も非常に良好であ
った。Group 1: 1-stearyl-3-carbamidopyrinonium chloride 1.0% cetostearyl alcohol 5.0 Squalane 10.0 Stearic acid 8.0 Beeswax 2.0 Olive oil 3.0 Fragrance 0.1 Preservative 0. 2 Group 2: 1.3-Butylene glycol 8.0 Glycerin 4.0 Purified water 58.7 The preparation procedure was exactly the same as in Example 1, and the obtained skin cream also showed excellent results in the oven test at 45°C. It was stable for more than a month, had no irritation, and had a very good feeling of use.
〔実施例4〕 つぎに示す組成のクレンノングクリームを調製した。[Example 4] A clean nongloss cream having the composition shown below was prepared.
第1群:
1−ベア ノル−3−ステアリル力ルバミドピリヅニウ
ムクロライド2.0%
セトステアリルアルコール 3.0
流動パラフイン 35.0
パラフインワツクス 2.0
バルミチン酸イソプロピル 10.0
第2群:
マルチトール 3.0
精製水 45.0
調製手順は実施例1と全く同じであり、得られたクレン
ジングクリームは45℃のオーブンテストにおいて3力
月以上も安定であり、刺激性がなく使用感も非常に良好
であった。Group 1: 1-bare nor-3-stearyl pyridunium chloride 2.0% Cetostearyl alcohol 3.0 Liquid paraffin 35.0 Paraffin wax 2.0 Isopropyl valmitate 10.0 Group 2: Maltitol 3.0 Purified water 45.0 The preparation procedure was exactly the same as in Example 1, and the resulting cleansing cream was stable for more than 3 months in an oven test at 45°C, was non-irritating, and had no feeling of use. It was very good.
〔実施例5〕 つぎに示す組成の化粧水を調製した。[Example 5] A lotion having the composition shown below was prepared.
第1群:
1−ラウリル−3−カルバミドピリヅニウムクロライド
0.60%香料 0.2゜
オレイルアルコール 0.04
1.3−ブチレングリコール 1.00グリセリン 1
,00
第2群:
クエン酸 0.07
精製水 97.06
すなわち、第1群からなる溶液に第2群の水溶液を加え
、均一透明に溶解するまで充分に撹拌した。得られた透
明化粧水は、皮膚に対する作用も温和であり、通常の化
粧水に配合されるエチルアルコールを使用することなく
、香料、オイル類を可溶化するために、肌lこ対する使
用感は非常に良好であった。Group 1: 1-lauryl-3-carbamidopyridunium chloride 0.60% fragrance 0.2゜oleyl alcohol 0.04 1.3-butylene glycol 1.00 glycerin 1
,00 Group 2: Citric acid 0.07 Purified water 97.06 That is, the aqueous solution of Group 2 was added to the solution of Group 1 and sufficiently stirred until it was uniformly and transparently dissolved. The resulting transparent lotion has a mild effect on the skin, and because it solubilizes fragrances and oils without using ethyl alcohol, which is included in regular lotions, it has a gentle effect on the skin. It was very good.
なお、実施例1〜5について、静菌効果を調べたところ
、少なくとも雑菌については顕著なものが認められた。In addition, when the bacteriostatic effect was investigated for Examples 1 to 5, a remarkable effect was observed at least for miscellaneous bacteria.
特許出願人 株式会社岩潮健次部商店 同 代理人 鎌 1) 文 二Patent applicant: Iwashio Kenjibe Shoten Co., Ltd. Same agent Kama 1) Sentence 2
Claims (1)
誘導体を含有することを特徴とする皮膚外用剤。 記 CAI CB] (式中、R1は炭素数8〜30の直鎖もしくは分枝アル
キル基、町は炭素数1〜30の直鎖もしくは分枝アルキ
ル基およびフェニル基、Xはハロゲン基を表わす。)[Scope of Claims] An external skin preparation characterized by containing a nicotinic acid derivative represented by the following general formula [A] or [B]. CAI CB] (In the formula, R1 represents a straight chain or branched alkyl group having 8 to 30 carbon atoms, Machi represents a straight chain or branched alkyl group having 1 to 30 carbon atoms and a phenyl group, and X represents a halogen group. )
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59052496A JPS60197611A (en) | 1984-03-19 | 1984-03-19 | External agent for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59052496A JPS60197611A (en) | 1984-03-19 | 1984-03-19 | External agent for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60197611A true JPS60197611A (en) | 1985-10-07 |
JPS6245201B2 JPS6245201B2 (en) | 1987-09-25 |
Family
ID=12916324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59052496A Granted JPS60197611A (en) | 1984-03-19 | 1984-03-19 | External agent for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60197611A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01104049A (en) * | 1986-08-07 | 1989-04-21 | Medice Chem Pharm Fab Puetter Gmbh & Co Kg | Medicine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56139462A (en) * | 1980-04-02 | 1981-10-30 | Agency Of Ind Science & Technol | Oxypyridine derivative and surface active agent comprising it |
JPS56139463A (en) * | 1980-04-02 | 1981-10-30 | Agency Of Ind Science & Technol | Aminopyridine derivative and surface active agent comprising it |
-
1984
- 1984-03-19 JP JP59052496A patent/JPS60197611A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56139462A (en) * | 1980-04-02 | 1981-10-30 | Agency Of Ind Science & Technol | Oxypyridine derivative and surface active agent comprising it |
JPS56139463A (en) * | 1980-04-02 | 1981-10-30 | Agency Of Ind Science & Technol | Aminopyridine derivative and surface active agent comprising it |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01104049A (en) * | 1986-08-07 | 1989-04-21 | Medice Chem Pharm Fab Puetter Gmbh & Co Kg | Medicine |
Also Published As
Publication number | Publication date |
---|---|
JPS6245201B2 (en) | 1987-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6391313A (en) | Medicine and antiacne cosmetic composition | |
US5019567A (en) | Benzoyl peroxide--quaternary ammonium lipophilic salicylate based pharmaceutical and cosmetic compositions and their use especially in treatment of acne | |
JPS60142920A (en) | Anti-acne agent | |
JPH0583528B2 (en) | ||
JP2001010925A (en) | Emulsified composition | |
JPH05301811A (en) | Beautifying and whitening cosmetic | |
DE60013947T2 (en) | (Poly) thia-alkyne compounds and their derivatives, compositions containing them and their use | |
GB2181051A (en) | Anti-acne compositions | |
FR2613719A1 (en) | AROMATIC DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIMICROBIALS | |
JPS609722B2 (en) | fair skin cosmetics | |
PL188033B1 (en) | Application of 1-hydroxy-2-pyridinones in treating seborrhoic dermatitis | |
JPH049310A (en) | Emulsified cosmetic | |
JPS60197611A (en) | External agent for skin | |
WO1990015588A1 (en) | Hair growth stimulant | |
JP2696523B2 (en) | Anti-dandruff agent and hair cosmetic | |
JPS63183518A (en) | Composition for hair | |
US2617753A (en) | Fungistatic preparations | |
DE60018647T2 (en) | Use of 4,6-dimethoxyindole-2-carboxylic acid or its derivatives for the treatment of seborrhoea | |
JPH07149622A (en) | Beautifying and whitening preparation | |
JPH03251516A (en) | Water-in-oil type emulsified cosmetic | |
JP3686772B2 (en) | Topical skin preparation | |
JPS6144814A (en) | Dermal drug for external use | |
JPS61130204A (en) | Skin cosmetic | |
JP2972416B2 (en) | Cosmetics | |
JP2609884B2 (en) | Skin cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |